NOVARTIS AG (NVSEF)
Clinical trial NCT06785675 updates: 1. completion date: 2026-09-30 → 2026-10-10 2. primary completion date: 2026-09-30 → 2026-10-10 3. enrollment: 48 → 53 participants
Clinical trial NCT06785675 updates: 1. completion date: 2026-09-30 → 2026-10-10 2. primary completion date: 2026-09-30 → 2026-10-10 3. enrollment: 48 → 53 participants
📉 **NEGATIVE** • Medium confidence analysis (62%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical